Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPT2 | P23786 | 1/20 | 0.39 |
| ▸ | CPT1A | P50416 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 15/20 | 0.39 |
| ▸ | NR1H3 | Q13133 | 12/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | MLYCD | O95822 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21962690 | 1.00 | CPT2 (0.39) | CPT2CPT1ANR1H2NR1H3CNR2 | |
| SCHEMBL22019320 | 0.97 | NR1H2 (0.39) | NR1H2NR1H3MLYCD | |
| SCHEMBL21962682 | 0.97 | NR1H2 (0.39) | NR1H2NR1H3MLYCD | |
| SCHEMBL22020535 | 0.89 | VNN1 (0.44) | NR1H2NR1H3MLYCD | |
| SCHEMBL21962341 | 0.89 | VNN1 (0.44) | NR1H2NR1H3MLYCD | |
| SCHEMBL22019319 | 0.89 | VNN1 (0.42) | LMNATSHR | |
| SCHEMBL21962626 | 0.89 | VNN1 (0.42) | LMNATSHR | |
| SCHEMBL21962518 | 0.86 | NR1H2 (0.42) | NR1H2NR1H3 | |
| SCHEMBL22019162 | 0.86 | NR1H2 (0.42) | NR1H2NR1H3 | |
| SCHEMBL21962448 | 0.86 | KRAS (0.41) | MLYCDLMNATSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020102575-A1 | HETEROCYCLIC AMINOTHIAZOLES AND USES THEREOF | INCEPTION IBD, INC. (US) | 2020-05-22 | — | — | WO | disclosed |